进行性半侧颜面萎缩的软组织重建:当前证据与未来方向
本文通过多数据库检索至2020年4月的临床研究,纳入35篇文章共824例进行性半侧颜面萎缩患者,其中503例(61%)接受显微血管游离皮瓣、302例(37%)接受自体脂肪移植、19例(2%)接受带蒂皮瓣治疗。文章详细综合了结局并比较了不同游离皮瓣选项,结论认为连续脂肪移植是轻度软组织萎缩的主要方法,而显微血管游离皮瓣仍是大容量缺损重建的首选。
要点
- 连续脂肪移植是轻度软组织萎缩患者的主要治疗方式。
- 显微血管游离皮瓣仍是大容量缺损重建的首选方法。
- 近期证据显示早期干预可能有助于遏制疾病进展。
核心结论
- 进行性半侧颜面萎缩的软组织重建仍是一个不断发展的领域。
- 手术决策常涉及多方面因素,并受特定容积、美学和功能缺陷的指导。
- 连续脂肪移植是轻度软组织萎缩患者的主要治疗方式,而显微血管游离皮瓣仍是大容量缺损重建的首选。
- 移植补充在改善脂肪移植存活方面的作用日益增加,近期证据表明早期干预可能有助于遏制疾病进展。
研究设计与样本
- 通过多数据库综合检索截至2020年4月的相关文献,纳入临床研究。
- 共评估35篇文章,报告824例进行性半侧颜面萎缩患者。
- 收集并批判性评价不同软组织重建策略的结局、并发症及疾病和患者相关指征。
主要发现
- 503例患者(61%)接受显微血管游离皮瓣治疗。
- 302例患者(37%)接受自体脂肪移植治疗。
- 19例患者(2%)接受带蒂皮瓣治疗。
- 文章详细综合了结局,并对不同显微血管游离皮瓣选项进行了比较评价。
临床怎么用
- 连续脂肪移植是轻度软组织萎缩患者的主要治疗方式。
- 显微血管游离皮瓣仍是大容量缺损重建的首选。
- 近期证据表明早期干预可能有助于遏制疾病进展。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Progressive hemifacial atrophy is a rare disorder characterized by gradual unilateral soft-tissue atrophy in the face, which may also include clinically significant degeneration of underlying muscle and bone. In recent years, there has been a growing body of evidence regarding different soft-tissue reconstructive strategies in progressive hemifacial atrophy and the impact of intervention timing on disease progression. This article provides a comprehensive synthesis of the latest evidence to guide optimal management. METHODS: A comprehensive multidatabase search was performed through April of 2020 using relevant search terms to identify clinical studies. Outcomes, complications, and disease- and patient-related indications pertaining to different soft-tissue reconstructive strategies in progressive hemifacial atrophy were collected and critically appraised. RESULTS: Thirty-five articles reporting on a total of 824 progressive hemifacial atrophy patients were evaluated; 503 patients (61 percent) were managed by microvascular free flaps, 302 patients (37 percent) were managed by autologous fat grafts, and 19 patients (2 percent) were managed by pedicled flaps. A detailed synthesis of outcomes is presented in this article, as is a comparative evaluation of different microvascular free flap options. CONCLUSIONS: Soft-tissue reconstruction in progressive hemifacial atrophy remains an evolving field. Operative decision-making is often multifaceted, and guided by specific volumetric, aesthetic, and functional deficiencies. Serial fat grafting is the primary modality used for patients with mild soft-tissue atrophy, whereas microvascular free flaps widely remain the treatment of choice for reconstruction of large-volume defects. There exists a growing role of graft supplementation to improve fat graft survival, whereas recent evidence demonstrates that early intervention may help curb disease progression.
引用
- Abi-Rafeh J, Jaberi M, Cattelan L, et al. Soft-Tissue Reconstruction in Progressive Hemifacial Atrophy: Current Evidence and Future Directions. Plast Reconstr Surg. 2022. PMID: 35791266. doi:10.1097/PRS.0000000000009423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。